𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intravenous injections of ibandronate (IB) in the treatment of postmenopausal osteoporosis

✍ Scribed by D. Thiébaud; H. Kriegbaum; H. Huss; C. Christiansen; P. Burckhardt

Book ID
105598845
Publisher
Springer-Verlag
Year
1996
Tongue
English
Weight
158 KB
Volume
6
Category
Article
ISSN
0937-941X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous ibandronate injections in po
Intravenous ibandronate injections in postmenopausal women with osteoporosis: One-year results from the dosing intravenous administration study
✍ Pierre D. Delmas; Silvano Adami; Cezary Strugala; Jacob A. Stakkestad; Jean-Yves 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

## Abstract ## Objective Although oral bisphosphonates are effective treatments for postmenopausal women with osteoporosis, oral dosing may be unsuitable for some patients. An efficacious intravenously administered bisphosphonate could be beneficial for such patients. Ibandronate, a potent nitroge

Administration of the bisphosphonate iba
Administration of the bisphosphonate ibandronate (BM 21.0955) by intravenous bolus injection
✍ Martin Pecherstorfer; Heinz Ludwig; Karl Schlosser; Signe Buck; Hermann-Josef Hu 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 615 KB

## Abstract Bisphosphonates (BPs) are used for the treatment of both benign and malignant diseases characterized by increased bone resorption. Because of their potential nephrotoxicity, currently available BPs have to be administered by slow intravenous infusion, with conventional doses requiring a